Metformin: A Promising Radiosensitizer in Neoadjuvant Rectal Cancer Treatment.

Reviews on recent clinical trials(2023)

引用 0|浏览7
暂无评分
摘要
Metformin might constitute a highly promising radiosensitizer in neoadjuvant LARC treatment attracting much scientific interest. Due to the lack of studies with high evidence, further advanced research is required to enhance the existing knowledge about its potential value in this field.
更多
查看译文
关键词
Colorectal cancer, LARC, metformin, radiosensitizer, neoadjuvant rectal cancer treatment, CRM
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要